GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort
David Pellerin(Montreal Neurological Institute and Hospital), Matthis Synofzik(German Center for Neurodegenerative Diseases), Bernard Brais(Montreal Neurological Institute and Hospital), Stephan Züchner(University of Miami), Matt C. Danzi(University of Miami), Alexanne Cuillerier(University of Ottawa), Dan Rujescu(Martin Luther University Halle-Wittenberg), Annette M. Hartmann(Duke University), Kym M. Boycott(Children's Hospital of Eastern Ontario), Andreas Traschütz(German Center for Neurodegenerative Diseases), Giulia Gobbo(University of Ottawa), Carlo Wilke(German Center for Neurodegenerative Diseases), Catherine Ashton(Royal Perth Hospital), Marie‐Josée Dicaire(Institute of Human Genetics), Felix Heindl(Ludwig-Maximilians-Universität München), Michael Strupp(Ludwig-Maximilians-Universität München), Jens Claaßen(Essen University Hospital)
Cited by 63
Related Papers
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
|Nature Genetics|2012|752
Disruption of the neurexin 1 gene is associated with schizophrenia
|Human Molecular Genetics|2008|485